HBM Healthcare Investments (Cayman) Ltd.
Insider CIK 1232258 · PTCT 10% owner · PRTK 10% owner · PCRX 10% owner · OPHT 10% owner · NBRV 10% owner · NBRV 10% owner · HOWL 10% owner · IOBT 10% owner · MLYS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 20,962,895 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 10,411,846 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-02-14 | 2023-02-16 | 312,500 | $16.00 | $5.00M | 3,218,106 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion | 2023-02-14 | 2023-02-16 | 1,941,368 | — | $0 | 1,941,368 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion | 2023-02-14 | 2023-02-16 | 964,238 | — | $0 | 2,905,606 | SEC↗ |
| IOBT IO Biotech, Inc. | C Conversion deriv | 2021-11-09 | 2021-11-12 | 188,168 | — | $0 | 0 | SEC↗ |
| IOBT IO Biotech, Inc. | P Buy | 2021-11-09 | 2021-11-12 | 325,000 | $14.00 | $4.55M | 2,690,545 | SEC↗ |
| IOBT IO Biotech, Inc. | C Conversion | 2021-11-09 | 2021-11-12 | 2,365,545 | — | $0 | 2,365,545 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-05 | 5,426,819 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-05 | 625,995 | — | $0 | 625,995 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-09-14 | 2017-09-14 | 3,429 | $8.52 | $29.2K | 2,334,128 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-09-13 | 2017-09-14 | 22,721 | $8.54 | $194.0K | 2,337,557 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-09-12 | 2017-09-14 | 10,458 | $8.63 | $90.3K | 2,360,278 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-08-31 | 2017-09-05 | 639 | $9.50 | $6.1K | 2,370,735 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-08-08 | 2017-08-09 | 2,013 | $10.50 | $21.1K | 2,371,374 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-08-07 | 2017-08-09 | 17,790 | $10.50 | $186.8K | 2,373,387 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-07-28 | 2017-08-01 | 6,585 | $10.51 | $69.2K | 2,391,177 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-07-24 | 2017-07-26 | 160 | $10.50 | $1.7K | 2,397,762 | SEC↗ |
| NBRV Nabriva Therapeutics Legac | S Sale | 2017-07-20 | 2017-07-21 | 23,445 | $10.50 | $246.2K | 2,397,922 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-07-20 | 2017-07-24 | 23,445 | $10.50 | $246.2K | 2,397,922 | SEC↗ |
| NBRV Nabriva Therapeutics Legac | S Sale | 2017-07-19 | 2017-07-21 | 20,786 | $10.50 | $218.3K | 2,421,367 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2017-07-19 | 2017-07-24 | 20,786 | $10.50 | $218.3K | 2,421,367 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | S Sale | 2017-07-18 | 2017-07-18 | 1,339 | $10.50 | $14.1K | 2,442,153 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | S Sale | 2017-07-17 | 2017-07-18 | 47,460 | $10.50 | $498.3K | 2,443,492 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | S Sale | 2017-07-14 | 2017-07-18 | 21,055 | $10.53 | $221.7K | 2,490,952 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | S Sale | 2017-07-13 | 2017-07-13 | 39,914 | $10.54 | $420.7K | 2,512,007 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | S Sale | 2017-07-12 | 2017-07-13 | 13,740 | $10.50 | $144.3K | 2,551,921 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | S Sale | 2017-07-11 | 2017-07-13 | 3,521 | $10.52 | $37.0K | 2,565,661 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | S Sale | 2017-07-07 | 2017-07-07 | 133 | $10.50 | $1.4K | 2,569,182 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | S Sale | 2017-07-05 | 2017-07-07 | 2,562 | $10.52 | $27.0K | 2,569,315 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-07-03 | 2017-07-05 | 11,352 | $10.95 | $124.3K | 2,571,877 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-06-30 | 2017-07-05 | 1,775 | $10.94 | $19.4K | 2,583,229 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-06-29 | 2017-06-29 | 1,603 | $10.72 | $17.2K | 2,585,004 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-06-28 | 2017-06-29 | 4,789 | $11.10 | $53.2K | 2,586,697 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-06-27 | 2017-06-29 | 2,166 | $10.83 | $23.5K | 2,591,396 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-06-01 | 2017-06-05 | 400 | $11.27 | $4.5K | 2,593,562 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-28 | 2017-04-28 | 15,130 | $11.03 | $166.9K | 2,593,962 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-27 | 2017-04-28 | 100 | $11.00 | $1.1K | 2,609,092 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-26 | 2017-04-28 | 709 | $11.00 | $7.8K | 2,609,192 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-21 | 2017-04-25 | 2,622 | $11.04 | $28.9K | 2,609,901 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-20 | 2017-04-20 | 325 | $11.00 | $3.6K | 2,612,523 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-19 | 2017-04-20 | 11,785 | $11.07 | $130.5K | 2,612,848 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-18 | 2017-04-20 | 11,822 | $11.16 | $131.9K | 2,624,633 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-13 | 2017-04-13 | 10,984 | $11.13 | $122.3K | 2,636,455 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-12 | 2017-04-13 | 13,250 | $11.22 | $148.7K | 2,647,439 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-11 | 2017-04-13 | 8,597 | $11.40 | $98.0K | 2,660,689 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-10 | 2017-04-10 | 37,876 | $10.73 | $406.4K | 185,394 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-10 | 2017-04-11 | 37,876 | $10.73 | $406.4K | 2,669,286 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-07 | 2017-04-10 | 18,001 | $10.96 | $197.3K | 223,270 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-07 | 2017-04-10 | 3,500 | $11.04 | $38.6K | 241,271 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-07 | 2017-04-11 | 3,500 | $11.04 | $38.6K | 2,725,163 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-07 | 2017-04-11 | 18,001 | $10.96 | $197.3K | 2,707,162 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-06 | 2017-04-10 | 6,617 | $11.28 | $74.6K | 269,371 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-06 | 2017-04-10 | 24,600 | $11.20 | $275.5K | 244,771 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-06 | 2017-04-11 | 6,617 | $11.28 | $74.6K | 2,753,263 | SEC↗ |
| NBRV Nabriva Therapeutics AG | S Sale | 2017-04-06 | 2017-04-11 | 24,600 | $11.20 | $275.5K | 2,728,663 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | S Sale | 2015-05-29 | 2015-06-01 | 3,700 | $30.25 | $111.9K | 1,747,680 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | S Sale | 2015-05-29 | 2015-06-01 | 6,300 | $29.52 | $186.0K | 1,751,380 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | S Sale | 2015-05-28 | 2015-06-01 | 2,365 | $32.16 | $76.1K | 1,757,680 | SEC↗ |
| PRTK Paratek Pharmaceuticals, I | S Sale | 2015-05-28 | 2015-06-01 | 8,215 | $31.52 | $258.9K | 1,760,045 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-05-13 | 2014-05-15 | 500,000 | $29.75 | $14.88M | 3,139,902 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2013-12-17 | 2013-12-19 | 66,667 | $19.08 | $1.27M | 2,441,504 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion deriv | 2013-09-30 | 2013-10-03 | 2,806,937 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion deriv | 2013-09-30 | 2013-10-03 | 398,208 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion deriv | 2013-09-30 | 2013-10-03 | 206,756 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion deriv | 2013-09-30 | 2013-10-03 | 13,670 | — | $0 | 13,670 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion deriv | 2013-09-30 | 2013-10-03 | 13,670 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion | 2013-09-30 | 2013-10-03 | 206,756 | — | $0 | 3,411,902 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion | 2013-09-30 | 2013-10-03 | 2,806,937 | — | $0 | 2,806,937 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion | 2013-09-30 | 2013-10-03 | 398,208 | — | $0 | 3,205,145 | SEC↗ |
| OPHT Ophthotech Corp. | P Buy | 2013-09-30 | 2013-10-03 | 228,000 | $22.00 | $5.02M | 3,639,902 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | C Conversion deriv | 2013-06-25 | 2013-06-28 | 1,561,317 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | C Conversion deriv | 2013-06-25 | 2013-06-28 | 280,178 | — | $0 | 0 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | C Conversion | 2013-06-25 | 2013-06-28 | 280,178 | — | $0 | 280,178 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | C Conversion | 2013-06-25 | 2013-06-28 | 1,561,317 | — | $0 | 1,841,495 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | P Buy | 2013-06-25 | 2013-06-28 | 666,676 | $15.00 | $10.00M | 2,508,171 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-25 | 2013-03-25 | 165,541 | $28.28 | $4.68M | 2,233,993 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-22 | 2013-03-25 | 113,928 | $27.52 | $3.14M | 2,399,534 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-21 | 2013-03-25 | 11,431 | $27.50 | $314.4K | 2,513,462 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-19 | 2013-03-21 | 9,100 | $27.86 | $253.5K | 2,524,893 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-21 | 400,000 | $28.19 | $11.28M | 2,533,993 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-11 | 2013-03-21 | 500,000 | $27.86 | $13.93M | 2,933,993 | SEC↗ |